{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T05:16:02Z","timestamp":1754111762038,"version":"3.38.0"},"reference-count":102,"publisher":"JLE","issue":"7","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.nephro.2013.05.002","type":"journal-article","created":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T00:30:41Z","timestamp":1373502641000},"page":"471-480","source":"Crossref","is-referenced-by-count":2,"title":["Le syndrome h\u00e9pator\u00e9nal\u00a0: mise au point"],"prefix":"10.1684","volume":"9","author":[{"given":"Victor","family":"Gueutin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimele","family":"Meftah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffroy","family":"Desbuissons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamis","family":"Debchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Lyse","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Shehwaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassane","family":"Izzedine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2013.05.002_bib0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/jhep.2003.50084","article-title":"Acute renal failure in patients with cirrhosis: perspectives in the age of MELD","volume":"37","author":"Moreau","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0010","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"first-page":"354","year":"2011","author":"Wong","key":"10.1016\/j.nephro.2013.05.002_bib0015"},{"key":"10.1016\/j.nephro.2013.05.002_bib0020","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0025","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.nephro.2013.05.002_bib0030","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.cgh.2010.03.029","article-title":"Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites","volume":"8","author":"Montoliu","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.nephro.2013.05.002_bib0035","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","author":"Gin\u00e8s","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2013.05.002_bib0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.nephro.2013.05.002_bib0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","year":"2010","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.nephro.2013.05.002_bib0050","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0055","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jhep.2011.03.012","article-title":"Diagnosis, treatment and survival of patients with hepatorenal syndrome: a survey on daily medical practice","volume":"55","author":"Salerno","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2013.05.002_bib0060","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0272-6386(82)80096-6","article-title":"Acute tubular necrosis in hepatorenal syndrome: an electron microscopy study","volume":"2","author":"Mandal","year":"1982","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2013.05.002_bib0065","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1478-3231.2009.02182.x","article-title":"The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study","volume":"30","author":"Trawal\u00e9","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.nephro.2013.05.002_bib0070","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1517\/14656566.2011.561200","article-title":"Hepatorenal syndrome","volume":"12","author":"Guevara","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.nephro.2013.05.002_bib0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0016-5085(82)90129-9","article-title":"Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary \u03b22-microglobulin to discriminate functional renal failure from acute tubular damage","volume":"82","author":"Cabrera","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0080","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1523-1755.1998.00968.x","article-title":"Ischemic renal diseases: new insights into old entities","volume":"54","author":"Meyrier","year":"1998","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.nephro.2013.05.002_bib0085","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1478-3231.2009.02182.x","article-title":"The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study","volume":"30","author":"Trawal\u00e9","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.nephro.2013.05.002_bib0090","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","article-title":"Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis","volume":"339","author":"Martin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2013.05.002_bib0095","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1478-3231.2008.01857.x","article-title":"Carbon monoxide produced by intrasinusoidally located haem-oxygenase-1\u00a0regulates the vascular tone in cirrhotic rat liver","volume":"29","author":"Van Landeghem","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.nephro.2013.05.002_bib0100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/gast.2002.30305","article-title":"Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat","volume":"122","author":"Ros","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0105","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/89953","article-title":"Endocannabinoids acting at vascular CB1\u00a0receptors mediate the vasodilated state in advanced liver cirrhosis","volume":"7","author":"B\u00e1tkai","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.nephro.2013.05.002_bib0110","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0168-8278(94)80096-0","article-title":"Intracellular calcium concentration in vascular smooth muscle cells of rats with cirrhosis","volume":"21","author":"Castro","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2013.05.002_bib0115","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/gut.2010.235473","article-title":"Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis","volume":"60","author":"M\u00f8ller","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.nephro.2013.05.002_bib0120","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis","volume":"20","author":"Follo","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","article-title":"Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features","volume":"45","author":"Fasolato","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0130","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/BF02777753","article-title":"Endotoxin levels in cirrhotic rats with sterile and infected ascites","volume":"27","author":"Sugano","year":"1992","journal-title":"Gastroenterol Jpn"},{"key":"10.1016\/j.nephro.2013.05.002_bib0135","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0168-8278(00)80272-X","article-title":"Effects of lipopolysaccharide on TNF-\u03b1 production, hepatic NOS2\u00a0activity, and hepatic toxicity in rats with cirrhosis","volume":"33","author":"Heller","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2013.05.002_bib0140","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI7458","article-title":"Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility","volume":"104","author":"Wiest","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nephro.2013.05.002_bib0145","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/jhep.2003.50038","article-title":"Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement","volume":"37","author":"Albillos","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/j.gastro.2005.04.016","article-title":"Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: role of Akt signaling","volume":"129","author":"Tazi","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0155","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1053\/jhep.2001.27093","article-title":"Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis","volume":"34","author":"Cejudo-Mart\u00edn","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0160","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.21785","article-title":"Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats","volume":"46","author":"Fernandez","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0165","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2010.03.021","article-title":"Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension","volume":"53","author":"Bosch","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2013.05.002_bib0170","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12072-008-9109-7","article-title":"Cirrhotic cardiomyopathy","volume":"3","author":"Wong","year":"2009","journal-title":"Hepatol Int"},{"key":"10.1016\/j.nephro.2013.05.002_bib0175","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1378\/chest.107.5.1467","article-title":"High-output congestive heart failure following transjugular intrahepatic portal-systemic shunting","volume":"107","author":"Braverman","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.nephro.2013.05.002_bib0180","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Gin\u00e8s","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0185","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/00007890-199604270-00011","article-title":"Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation","volume":"61","author":"Donovan","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2013.05.002_bib0190","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/lt.500040513","article-title":"Post-liver transplantation myocardial dysfunction","volume":"4","author":"Sampathkumar","year":"1998","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.nephro.2013.05.002_bib0195","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.nephro.2013.05.002_bib0205","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","article-title":"Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis","volume":"38","author":"Ruiz-del-Arbol","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2007.10.055","article-title":"Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis","volume":"134","author":"Stadlbauer","year":"2008","journal-title":"Gastroenterology"},{"issue":"Suppl. 2","key":"10.1016\/j.nephro.2013.05.002_bib0215","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1016\/S0168-8278(12)60666-7","article-title":"Is type 1\u00a0hepatorenal syndrome reversible after liver transplantation?","volume":"56","author":"Leung","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2013.05.002_bib0220","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1478-3231.2008.01877.x","article-title":"Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study","volume":"29","author":"Terg","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.nephro.2013.05.002_bib0225","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/gut.2006.113050","article-title":"Restricted use of albumin for spontaneous bacterial peritonitis","volume":"56","author":"Sigal","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.nephro.2013.05.002_bib0230","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cgh.2011.11.012","article-title":"Role of albumin in the treatment in patients with spontaneous bacterial peritonitis","volume":"10","author":"Poca","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.nephro.2013.05.002_bib0235","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2013.05.002_bib0240","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2036.2011.04746.x","article-title":"Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding \u2013 an updated Cochrane review","volume":"34","author":"Chavez-Tapia","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.nephro.2013.05.002_bib0245","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fern\u00e1ndez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0250","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1053\/j.gastro.2010.01.040","article-title":"Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis","volume":"138","author":"Lebrec","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0255","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0260","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007339.pub2","article-title":"Pentoxifylline for alcoholic hepatitis","volume":"4","author":"Whitfield","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nephro.2013.05.002_bib0265","first-page":"9","article-title":"Incidence and characteristics of type 2\u00a0hepatorenal syndrome in patients with cirrhosis and refractory ascites","volume":"71","author":"Serst\u00e9","year":"2008","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.nephro.2013.05.002_bib0270","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MCC.0b013e3283455c57","article-title":"Acute-on-chronic liver failure: from concept to a new syndrome","volume":"17","author":"Jalan","year":"2011","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.nephro.2013.05.002_bib0275","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/MCC.0b013e328344b42d","article-title":"Acute-on-chronic liver failure: concept, natural history, and prognosis","volume":"17","author":"Olsen","year":"2011","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.nephro.2013.05.002_bib0280","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/hep.23264","article-title":"Severe sepsis in cirrhosis","volume":"50","author":"Gustot","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0285","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2008-1040323","article-title":"Pathogenesis and treatment of hepatorenal syndrome","volume":"28","author":"Arroyo","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.nephro.2013.05.002_bib0290","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1586\/17474124.1.2.207","article-title":"Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome","volume":"1","author":"Saner","year":"2007","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.nephro.2013.05.002_bib0295","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1440-1746.1990.tb01439.x","article-title":"A controlled study of glypressin versus vasopressin in the control of bleeding from oesophageal varices","volume":"5","author":"Chiu","year":"1990","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.nephro.2013.05.002_bib0300","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1\u00a0hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0305","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Mart\u00edn-Llah\u00ed","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0310","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","article-title":"Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics","volume":"55","author":"Boyer","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2013.05.002_bib0315","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1\u00a0hepatorenal syndrome","volume":"51","author":"Nazar","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0320","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ncpgasthep0680","article-title":"Drug insight: the role of albumin in the management of chronic liver disease","volume":"4","author":"Wong","year":"2007","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"13","key":"10.1016\/j.nephro.2013.05.002_bib0325","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gin\u00e8s","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2013.05.002_bib0330","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.23286","article-title":"Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome","volume":"51","author":"Gluud","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0335","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1440-1746.2009.06132.x","article-title":"Terlipressin therapy for reversal of type 1\u00a0hepatorenal syndrome: a meta-analysis of randomized controlled trials","volume":"25","author":"Sagi","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl.","key":"10.1016\/j.nephro.2013.05.002_bib0340","first-page":"378A","article-title":"Terlipressin given as continuous intravenous infusion is the more suitable schedule for the treatment of type 1\u00a0hepatorenal syndrome (HRS) in patients with cirrhosis: results of a controlled clinical trial","volume":"48","author":"Angeli","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0345","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/j.gastro.2009.03.064","article-title":"Terlipressin for hepatorenal syndrome: continuous infusion as an alternative to i.v. bolus administration","volume":"137","author":"Gerbes","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0350","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jhep.2011.02.002","article-title":"Continuous recurrence of type 1\u00a0hepatorenal syndrome and long-term treatment with terlipressin and albumin: a new exception to MELD score in the allocation system to liver transplantation?","volume":"55","author":"Piano","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2013.05.002_bib0355","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1\u00a0hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0360","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin and TIPS in selected patients with cirrhosis and type 1\u00a0hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0365","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s10620-006-9312-0","article-title":"Octreotide\/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1\u00a0hepatorenal syndrome","volume":"52","author":"Esrailian","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"Suppl. 1","key":"10.1016\/j.nephro.2013.05.002_bib0370","first-page":"1426A","article-title":"Terlipressin and albumin vs. midodrine plus octreotide and albumin in the treatment of hepatorenal syndrome in patients with cirrhosis: results of a controlled clinical trial by the Italian Association for the Study of the Liver","volume":"54","author":"Cavallin","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0375","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/TP.0b013e31821690bf","article-title":"Liver transplant outcomes for patients with hepatorenal syndrome treated with pretransplant vasoconstrictors and albumin","volume":"91","author":"Rice","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2013.05.002_bib0380","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1\u00a0hepatorenal syndrome and predictors of response","volume":"103","author":"Sharma","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.nephro.2013.05.002_bib0385","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.nephro.2013.05.002_bib0390","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline versus terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2013.05.002_bib0395","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0400","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(97)24010-9","article-title":"Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome","volume":"349","author":"Brensing","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2013.05.002_bib0405","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.nephro.2013.05.002_bib0410","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0168-8278(02)00334-3","article-title":"Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis","volume":"38","author":"Jalan","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2013.05.002_bib0415","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/j.transproceed.2005.06.048","article-title":"Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure","volume":"37","author":"Di Campli","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nephro.2013.05.002_bib0420","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/lv.2000.6355","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.nephro.2013.05.002_bib0425","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/gut.2008.174615","article-title":"Molecular adsorbent recirculating system is ineffective in the management of type 1\u00a0hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment","volume":"59","author":"Wong","year":"2010","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.nephro.2013.05.002_bib0430","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jhep.2009.02.002","article-title":"Endothelin-receptor antagonist\/N-acetylcysteine combination in type 1\u00a0hepatorenal syndrome","volume":"50","author":"Izzedine","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2013.05.002_bib0435","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1053\/gast.1997.v113.pm9247479","article-title":"Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis","volume":"113","author":"Ruiz-del-Arbol","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0440","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0445","first-page":"1753","article-title":"Type-2\u00a0hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation","volume":"50","author":"Testino","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0450","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/00042737-200212000-00013","article-title":"Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2","volume":"14","author":"Alessandria","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.nephro.2013.05.002_bib0455","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00007890-199102000-00030","article-title":"Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome \u2013 experience in 300\u00a0patients","volume":"51","author":"Gonwa","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2013.05.002_bib0460","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0465","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","article-title":"Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study","volume":"40","author":"Restuccia","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2013.05.002_bib0470","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1023\/A:1021763221337","article-title":"Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis","volume":"48","author":"Cassinello","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.nephro.2013.05.002_bib0475","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1523-1755.2005.00408.x","article-title":"Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy","volume":"68","author":"Wong","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2013.05.002_bib0480","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ndt\/gfi212","article-title":"The course of type\u00a01\u00a0hepatorenal syndrome post liver transplantation","volume":"21","author":"Marik","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2013.05.002_bib0485","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/hep.1840170202","article-title":"Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients","volume":"17","author":"Hadengue","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2013.05.002_bib0490","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1600-6143.2007.01856.x","article-title":"Simultaneous liver-kidney transplantation: evaluation to decision making","volume":"7","author":"Davis","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2013.05.002_bib0495","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/TP.0b013e318168476d","article-title":"Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts","volume":"85","author":"Locke","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2013.05.002_bib0500","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MOT.0b013e328338f638","article-title":"Combined liver and kidney transplantation","volume":"15","author":"Papafragkakis","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.nephro.2013.05.002_bib0505","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2036.2009.04096.x","article-title":"Ascites improves upon serum sodium plus model for end-stage liver disease (MELD) for predicting mortality in patients with advanced liver disease","volume":"30","author":"Somsouk","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.nephro.2013.05.002_bib0510","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/lt.22218","article-title":"Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk","volume":"17","author":"Somsouk","year":"2011","journal-title":"Liver Transpl"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725513000977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725513000977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2013.05.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:45:32Z","timestamp":1741185932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725513000977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":102,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1769725513000977"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2013.05.002","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}